To assess the potential of inhibiting toxic signaling originating from esNMDARs to normalize such dysregulation, we used the zQ175 mouse model of HD, which harbors an expanded CAG repeat knock-in in its Htt gene53. The gene discussed is HTT; the disease is Huntington disease.